State Street Corp 89bio, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in 89bio, Inc. stock. As of the latest transaction made, State Street Corp holds 3,251,687 shares of ETNB stock, worth $28.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,251,687

Previous 3,244,503 0.22%

Holding current value

$28.7 Million

Previous $26 Million 7.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $52,874 - $69,397	7,184 Added 0.22%	3,251,687 $24.1 Million
Q2 2024 Aug 14, 2024	SELL	$7.31 - $10.9 $16.8 Million - $25.1 Million	-2,299,085 Reduced 41.47%	3,244,503 $26 Million
Q1 2024 May 15, 2024	BUY	$8.13 - $13.77 $1.17 Million - $1.99 Million	144,230 Added 2.67%	5,543,588 $64.5 Million
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $7.28 Million - $17.5 Million	1,092,718 Added 25.37%	5,399,358 $60.3 Million
Q3 2023 Nov 14, 2023	SELL	$15.06 - $19.41 $5.07 Million - $6.53 Million	-336,551 Reduced 7.25%	4,306,640 $66.5 Million
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $22.3 Million - $34.6 Million	1,572,817 Added 51.23%	4,643,191 $88 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $31.1 Million - $50.2 Million	2,965,364 Added 2823.89%	3,070,374 $46.8 Million
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $232,391 - $535,933	42,100 Added 66.92%	105,010 $1.34 Million
Q3 2022 Nov 15, 2022	BUY	$3.02 - $7.0 $96,942 - $224,700	32,100 Added 104.19%	62,910 $364,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $246,243 - $473,636	-117,820 Reduced 79.27%	30,810 $99,000
Q1 2022 May 16, 2022	BUY	$3.45 - $14.99 $6,230 - $27,071	1,806 Added 1.23%	148,630 $560,000
Q4 2021 Feb 14, 2022	SELL	$11.15 - $19.66 $6,455 - $11,383	-579 Reduced 0.39%	146,824 $1.92 Million
Q3 2021 Nov 15, 2021	SELL	$14.91 - $21.31 $13,791 - $19,711	-925 Reduced 0.62%	147,403 $2.89 Million
Q2 2021 Aug 16, 2021	BUY	$17.42 - $28.0 $463,023 - $744,240	26,580 Added 21.83%	148,328 $2.77 Million
Q1 2021 May 17, 2021	BUY	$20.22 - $26.73 $1,536 - $2,031	76 Added 0.06%	121,748 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $873,409 - $1.06 Million	37,712 Added 44.92%	121,672 $2.97 Million
Q3 2020 Nov 10, 2020	BUY	$24.34 - $38.82 $781,946 - $1.25 Million	32,126 Added 61.98%	83,960 $2.15 Million
Q2 2020 Aug 14, 2020	BUY	$19.93 - $31.2 $74,697 - $116,937	3,748 Added 7.79%	51,834 $1.03 Million
Q1 2020 May 11, 2020	BUY	$16.4 - $41.77 $788,610 - $2.01 Million	48,086 New	48,086 $1.21 Million

Others Institutions Holding ETNB

# of Institutions

158

Shares Held

108M

Call Options Held

73.6K

Put Options Held

1.19M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $410M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp 89bio, Inc. Transaction History